Idelalisib

Zydelig 100 mg comprimidos recubiertos con pelicula

100 mg comprimido recubierto con películaSpainMarketedAuthorised 27 Oct 2014

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Idelalisib

Zydelig 100 mg comprimidos recubiertos con pelicula

100 mg comprimido recubierto con películaSpainMarketedAuthorised 27 Oct 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ZYDELIG Tablets 100MGTaiwan · 膜衣錠 · 香港商吉立亞醫藥有限公司台灣分公司

ZydeligUnited States · 100MG, 150MG · tablet · Gilead Sciences INC

IdelalisibUnited States · 100MG, 150MG · tablet · Natco

Packs

Pack	Code	Status
Zydelig 100 mg comprimidos recubiertos con pelicula 60 comprimidos recubiertos con película y un relleno de poliéster	703994

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Idelalisib
Strength: 100 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 27 Oct 2014
Registration: 114938001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Diagnóstico Hospitalario